Navigation Links
Craneware Announces Fiscal Year-End Results
Date:9/8/2009

ATLANTA, Sept. 8 /PRNewswire/ -- Craneware, Inc. (AIM: CRW.L), a leader in sustainable financial improvement solutions for the U.S. healthcare market, is pleased to announce results for the year ended June 30, 2009.

Financial Highlights

  • Record levels of contracted sales in the year totaling $43.2m (FY08: $25.7m), 68% up from the previous year, contributing to:
    • 23% increase in revenues to $23.0m (FY08: $18.7m)
    • 51% increase in future revenues under contract to $60.1m (FY08:$39.9m)
  • Profit before share based payments, depreciation and amortization increased 29% to $5.8m (FY08: $4.5m)
  • Profit before taxation increased by 40% to $5.9m (FY08: $4.2m)
  • Cash position increased 24% to $26.1m (FY08 $21.1m)
  • Basic EPS increased to $0.18 (FY08: $0.14) and diluted to $0.17 (FY08: $0.13)
  • Final dividend proposed of 2.9p (4.77 cents) per share giving a total dividend for the year of 4.7p (7.43 cents) per share (FY08: 3.1p (4.96 cents) per share)

Operational Highlights

  • New product lines contributed $10.1m (23%) to total contracted sales during the year
  • Extended market reach through partnership deals with Premier, Amerinet and Perot
  • Signed significant reseller agreement with McKesson Corporation post year-end
  • Accelerated investment in sales and marketing activities
  • Proposed U.S. Healthcare reforms trend toward increased regulation and new market opportunities

Keith Neilson, CEO of Craneware, commented, "The U.S. healthcare system is currently undergoing an unprecedented level of change and public scrutiny. This combined with the global economic downturn means healthcare organizations are experiencing extraordinary levels of fiscal and legislative pressure. Craneware continues to invest in the development and deployment of software to help manage these pressures and we believe that our market leading position and reputation within the industry, combined with our strong business fundamentals, leaves us well positioned to serve this growing demand.

"The signing of a significant value-added reseller agreement with McKesson Corporation, the world's largest healthcare services company, at the beginning of this new fiscal year has given us a strong start. The agreement sees McKesson integrate Craneware's Chargemster Toolkit(R) software with their next generation hospital information system (HIS), Horizon Enyterprise Revenue Management(TM) as part of their ongoing legacy system replacement and upgrading program. This new agreement, combined with a growing Craneware sales pipeline and the launch of further products by the end of the current year, gives us confidence we are on track to continue our history of significant growth in the year ahead."

About Craneware

Craneware (AIM: CRW.L) partners with healthcare organizations to improve returns, increase productivity and manage risk, driving sustainable financial and operational performance improvements using market-led revenue management solutions. By enhancing revenue capture processes, Craneware SaaS solutions allow those organizations to optimize reimbursement, improve operational efficiency, and support compliance. Visit craneware.com.

A full copy of the Company's Year-End Results can be found on Craneware's Web site at http://craneware.com. In the Investors area of the Web site, click on Financial Reports.

This document does not constitute an offer to sell or issue or the solicitation of an offer to buy or subscribe for Ordinary Shares in any jurisdiction in which such offer or solicitation is unlawful.


'/>"/>
SOURCE Craneware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Craneware to Highlight Best Practices for Optimizing Revenue Capture Processes in Two Seminar Presentations during HFMAs 2009 ANI: The Healthcare Finance Conference
2. Craneware Supports Hospitals Compliance and Upfront Collections with Accurate Estimates
3. Craneware Appoints New Non-Executive Director
4. Craneware to Offer Financial Performance Solutions to Hospitals and Healthcare Providers Through Premier, the Largest U.S. Healthcare Alliance
5. Craneware and St. Joseph to Present Revenue Enhancement Success Story at HIMSS
6. Craneware Announces Half-Year Results
7. Cochlear Americas Announces FDA Approval of the Nucleus(R) 5 System, the Newest and Most Advanced Cochlear Implant System
8. Medizone International, Inc. Announces OTCBB Listing
9. PPJ Enterprise Announces New Acquisition
10. Migraine Research Foundation Announces Winners of 2009 Research Grants
11. Asymchem Announces Fall Process Symposium Confirmed List of Speakers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding ... God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with ... Walk with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, ...
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... “The Adventures ... loving, smart and silly dog who lives his life to the fullest, as God ... of published author Patti Holmgren, a mother and grandmother pursuing her passion for writing, ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the National Council on ... The NCTQ report suggests, based on a review of GPA and SAT/ACT requirements at ... in the U.S. It argues that this higher bar should be set by states, ...
(Date:3/23/2017)... Virginia (PRWEB) , ... March 23, 2017 , ... ... public health services to their communities, 16 more public health departments have been ... week’s decisions bring another 4.5 million people into the expanding network of communities ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 ... research report created through extensive primary research (inputs ... the report aims to present the analysis of ... of Procedure (Replacement and Repair); Replacement Procedure By ... Repair By Technique (Surgical Devices, Balloon Valvuloplasty, Transcatheter ...
(Date:3/23/2017)... March 23, 2017  The U.S. Food and Drug ... the treatment of adults and pediatric patients 12 years ... those who have not received prior chemotherapy. This is ... aggressive form of skin cancer. "While skin ... with a rare form called Merkel cell cancer have ...
(Date:3/23/2017)... and VANCOUVER, British Columbia , ... SPHS ) (the "Company" or "Sophiris"), a clinical ... of urological diseases, today announced that data from its ... drug as a focal treatment for localized prostate cancer, ... 2017 at the 32 nd Annual European Association ...
Breaking Medicine Technology: